White, H.D.

patient trial stroke study infarction mortality /iiia treatment death baseline hemorrhage glycoprotein table therapy event group 30- day mortality outcome nonhemorrhagic stroke analysis syndrome effect 30 days predictor heart difference nonhemorrhagic ratio model investigator elevation gusto thrombolytic 30- hospital heparin intracranial result survival placebo inhibitor receptor in-hospital streptokinase disease platelet cardiogenic shock intervention troponin thrombolytic therapy intracranial hemorrhage factor circulation pursuit reduction country resource arrhythmia characteristic angina subgroups age subgroups follow-up gusto-i atrial fibrillation /flutter randomized increase hospitalization <0·001 blocker cost-effectiveness procedure non-st-segment elevation university shock month benefit baseline characteristics lancet catheterization